NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression. Here, NLRP3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.